Clinical-Microbiomics A/S — Credit Rating and Financial Key Figures

Clinical-Microbiomics A/S (CVR number: 37230634K) is a company from KØBENHAVN. The company recorded a gross profit of 10.7 mEUR in 2024. The operating profit was -7280 kEUR, while net earnings were -9137 kEUR. The profitability of the company measured by Return on Assets (ROA) was -7.1 %, which can be considered poor and Return on Equity (ROE) was -10.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 81.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Clinical-Microbiomics A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.